Archon Biosciences is a startup, most recent round Series A.
Archon Biosciences is a startup. Its most recent tracked round is Series A.
Archon Biosciences uses AI-generated protein structures to improve the delivery of antibody therapies targeting specific areas of the body.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.